Zuglimin 500mg Tablet

Zuglimin 500mg Tablet
Imeglimin (500mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Zuglimin 500mg Tablets
Imeglimin (500mg) tablets, under the brand name Zuglimin, are prescribed to treat individuals with Type 2 Diabetes. This once daily tablet is designed to control blood sugar levels by working directly on glucose metabolism. It's a key component of comprehensive diabetes management alongside lifestyle modifications like diet and exercise.
How Zuglimin works: Imeglimin acts as a glucagon-like peptide-1 receptor (GLP-1) agonist. This mechanism enhances insulin release from the pancreas, thereby lowering blood sugar levels.
Dosage: The recommended dosage for Zuglimin is 500mg, taken once daily with or without food. Dosage adjustments may be made under your healthcare provider's guidance based on individual needs and response to treatment.
Important Note: This medication should only be used under the supervision of a qualified medical professional. It's crucial to adhere to prescribed dosages and follow instructions carefully for optimal effectiveness and safety.
Active composition
Imeglimin 500 mg
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
Customer Reviews
0 reviews for Zuglimin 500mg Tablet
Products matching your search

Insugen 30/70 100IU Refil Cartridge

Insugen 30/70 100IU Refil Cartridge

Zymride M 3 Forte Tablet PR

Zymride M 3 Forte Tablet PR

Jodapa 5mg Tablet

Jodapa 5mg Tablet

Zoryl M 3 Forte Tablet PR

Zoryl M 3 Forte Tablet PR

Esipram 10 Tablet

Esipram 10 Tablet

Linero D 10mg/5mg Tablet

Linero D 10mg/5mg Tablet

Xenia 10 Tablet

Xenia 10 Tablet

K-Glim-M Forte 2mg Tablet
